Electroencephalography (EEG) is one of the most important diagnostic tools in epilepsy care, but access to it is profoundly unequal. In some health systems, routine EEG, ambulatory EEG, video-EEG and specialist interpretation are readily available. In others, a person may live hundreds of miles from the nearest machine, wait months for testing, or have no realistic access at all.
The global problem is not simply a shortage of machines. Effective EEG services require trained technicians, reliable electricity, functioning equipment, consumables, maintenance, data storage, infection control, appropriate recording protocols and clinicians who can interpret the results accurately.
EEG is useful — but epilepsy is not diagnosed by EEG alone
Epilepsy remains a clinical diagnosis supported by investigations. WHO guidance for low-resource settings explicitly states that when there is convincing clinical evidence of convulsive epilepsy, treatment should not be delayed simply because EEG is unavailable.
This distinction matters globally. A health system should expand EEG access, but lack of EEG must not become a reason to deny treatment to someone with a clear seizure disorder.
What EEG adds
EEG can support diagnosis, help classify seizure type and epilepsy syndrome, identify interictal epileptiform discharges, guide medicine choice, contribute to recurrence-risk assessment after a first seizure, and support presurgical evaluation.
More advanced forms such as prolonged video-EEG can help distinguish epileptic from non-epileptic events, capture nocturnal seizures and clarify seizure onset and evolution.
The access gap is global
Nearly 80% of people with epilepsy live in low- and middle-income countries. WHO also reports major shortages of neurological services and specialists in many lower-income settings, with particularly large inequalities between urban and rural populations.
Where neurologists, neurophysiologists and trained EEG technologists are scarce, the practical availability of EEG falls even further. A machine in a national referral hospital does not equal meaningful access for someone living far away without affordable transport.
Urban concentration creates a second treatment gap
Diagnostic technology is often concentrated in capital cities and tertiary hospitals. People in rural or remote areas may face travel costs, lost wages, accommodation expenses and long journeys simply to reach a test.
This means the diagnostic gap can persist even in countries that technically possess EEG equipment.
A machine without expertise is not enough
EEG is easy to overinterpret and easy to underinterpret. Benign variants, movement artefact, drowsiness patterns and normal background rhythms can be mistaken for epileptiform activity, while genuine abnormalities can be missed.
Good EEG services therefore require both technical quality and expert interpretation. Expanding hardware without building interpretation capacity can create misdiagnosis rather than solve it.
Why technical quality matters
Poor electrode contact, inadequate recording time, missing activation procedures, excessive artefact or incorrectly placed electrodes can reduce diagnostic value. International standards exist for electrode placement and recording practice, but low-resource services may struggle to meet them consistently.
Consumables and maintenance are recurring costs. Even donated EEG equipment can become unusable if replacement parts, electrodes, paste, amplifiers or software support are unavailable.
Routine EEG is only one level of access
Global access should not be measured simply as ‘EEG available’ or ‘EEG unavailable’. There are several levels:
- routine outpatient EEG;
- sleep or sleep-deprived EEG;
- ambulatory EEG;
- prolonged inpatient video-EEG;
- continuous EEG in intensive care;
- high-density EEG;
- intracranial EEG for presurgical evaluation.
A country may have routine EEG yet no realistic access to prolonged monitoring, paediatric neurophysiology or presurgical testing.
Paediatric EEG requires additional expertise
EEG changes markedly with age. Normal neonatal, infant and childhood patterns differ from adult recordings, and many epilepsy syndromes have age-specific EEG features.
Where paediatric neurophysiology expertise is scarce, children may be particularly vulnerable to delayed or inaccurate diagnosis.
Video-EEG is even less accessible
Video-EEG requires beds, cameras, continuous recording infrastructure, trained staff and specialist review. These resources are concentrated in tertiary epilepsy centres even in many high-income countries.
For people with uncertain events, possible functional seizures, nocturnal episodes or drug-resistant epilepsy, lack of video-EEG can prolong diagnostic uncertainty for years.
Continuous EEG in intensive care
Continuous EEG is particularly important for detecting non-convulsive seizures and non-convulsive status epilepticus in critically ill patients. Yet this form of monitoring requires 24-hour technical and interpretive support and is unavailable in many hospitals worldwide.
The result is an important hidden disparity: some seizures are not only untreated but never detected.
Cost can make a test effectively unavailable
Even where EEG exists, out-of-pocket fees can make it inaccessible. Families may also have to pay for travel, food, accommodation and time away from work.
In health systems with limited public coverage, the full cost of obtaining an EEG may therefore be much greater than the test fee itself.
Waiting time is another form of limited access
A service can exist on paper yet remain inaccessible if waiting lists are extremely long. Delays can affect diagnosis, driving advice, medicine decisions, school planning, employment and referral for specialist care.
For time-sensitive questions such as possible status epilepticus or infantile epileptic spasms, delayed EEG can have greater clinical consequences.
Portable EEG may help close the gap
Portable and lower-cost EEG systems are increasingly being studied for use in remote and low-resource settings. Their potential advantages include easier transport, lower infrastructure requirements and the possibility of recording closer to where people live.
But portability does not remove the need for quality control, training or expert interpretation. A cheaper machine is useful only if the recordings are technically reliable and clinically interpreted correctly.
Tele-EEG can separate recording from interpretation
Digital EEG makes it possible for a recording to be performed in one location and interpreted elsewhere. Tele-neurophysiology can therefore extend specialist expertise across regions without requiring every hospital to employ a full-time neurophysiologist.
This model depends on reliable internet connectivity, secure data transfer, standardised recording quality and sustainable specialist capacity. It can redistribute expertise, but it cannot fully solve shortages if there are too few trained interpreters overall.
Training non-specialist staff
Task sharing is already central to global epilepsy care. WHO supports expanding the role of primary care and allied health professionals in epilepsy diagnosis and management in low-resource settings.
For EEG, this can include training local staff to prepare patients, apply electrodes correctly, recognise artefact and upload recordings for remote interpretation. Interpretation itself still requires appropriately trained clinicians.
AI may assist — but should not be used to justify removing expertise
Automated EEG analysis and machine-learning tools are being developed to flag possible epileptiform discharges or seizures. In principle, these systems could help triage large volumes of recordings in settings with few specialists.
However, performance can vary between populations, devices and recording quality. False positives and false negatives remain important concerns. AI should therefore be evaluated as decision support rather than assumed to replace expert interpretation.
A normal EEG does not rule out epilepsy
This point becomes especially important when access is limited. Routine EEG samples a short period of brain activity, and many people with epilepsy have no epileptiform discharge during that recording.
Repeated EEG, sleep recording or prolonged monitoring can increase yield, but those options are precisely the ones least available in many parts of the world.
An abnormal EEG does not automatically mean epilepsy
Some EEG abnormalities are non-specific, and epileptiform-appearing patterns can occasionally occur in people without clinical epilepsy. Diagnosis must therefore integrate EEG with the clinical history.
This is another reason interpretation quality matters as much as hardware availability.
Why access matters for medicine choice
Seizure classification affects treatment. Some antiseizure medicines are effective for particular seizure types but may be inappropriate or less suitable for others.
When EEG helps identify a generalised versus focal epilepsy pattern, it can improve diagnostic confidence and guide treatment more precisely. Without EEG, clinicians may have to make decisions with less information.
Why access matters for surgery
Presurgical assessment usually requires substantially more than a routine EEG. Prolonged video-EEG is commonly used to capture habitual seizures and compare electrical onset with MRI, semiology and other investigations.
Countries without advanced EEG services are therefore also less able to identify candidates for potentially curative epilepsy surgery.
WHO now explicitly includes EEG among essential diagnostic tools
WHO’s implementation guidance for the Intersectoral Global Action Plan on epilepsy and other neurological disorders calls on health systems to ensure access to essential diagnostic tools, including EEG and neuroimaging.
This is important because global epilepsy policy cannot focus only on medicine supply. Diagnosis, classification and referral infrastructure are part of the treatment gap too.
What better global EEG access would require
Closing the gap requires more than purchasing equipment. Sustainable programmes need workforce training, maintenance contracts, replacement consumables, electricity and connectivity, quality standards, paediatric expertise, tele-interpretation networks, referral pathways and financing that does not shift unaffordable costs onto families.
EEG capacity also needs to be distributed beyond major capitals so that rural populations are not excluded by geography.
What this page does — and does not — explain
This page is about worldwide access to EEG services. The technical meaning of EEG findings is covered on EEG Explained Properly; prolonged monitoring is covered on Video-EEG Monitoring; and the broader geographic inequalities in care are covered on the Global Epilepsy and rural–urban treatment-gap pages.
Sources
World Health Organization — Epilepsy fact sheet
WHO mhGAP — Role of EEG in management of epilepsy
WHO — IGAP implementation toolkit
WHO/WFN — Atlas: Country Resources for Neurological Disorders, 2nd ed.
Global Health and Epilepsy: Update and Future Directions
Instruments for investigation of epilepsy in low- and middle-income countries: systematic review
Evidence checked: September 2026.